Clinical Study of ATTR-CM

Recruiting now · Phase 4

Conditions studied: Transthyroxine Amyloidosis Cardiomyopathy

In brief

In this study, patients with ATTR-CM or gene carriers were selected to study the diagnosis and treatment, and long-term follow-up was conducted.

Key facts

Study ID

NCT04935021

Run by

Second Affiliated Hospital, Zhejiang University, School of Medicine

People needed

100

Starts

2021-06-01

Expected to finish

2031-06-01

Last updated by the study team

2023-01-31

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients and gene carriers of ATTR-CM confirmed in the Second Affiliated Hospital of Zhejiang University School of Medicine, regardless of gender, age 18-90 years old;
• Patients who have the ability to understand the test and can cooperate with investigators

You may not qualify if…

• Patients who unable to understand or unwilling to fill in informed consent forms or follow visitors

Where it is running

• xiaohong University PAN — Hangzhou, Zhejiang, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.